Frederick Locke

41PUBLICATIONS

282CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Radiation therapyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (41)

Sort by Publication Date:

|May 11, 2026

Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.

|Apr 08, 2026

Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).

Reshma Ramlal, Jongphil Kim, Zachary Thompson

|Nov 13, 2025

Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial.

Caron A Jacobson, Jason R Westin, David B Miklos

|Jul 07, 2025

Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma.

Assia Hijazi, Frederick L Locke, Nathalie Scholler

|Jun 23, 2025

Reply to: Optimizing Allogeneic Chimeric Antigen Receptor T-Cell Persistence in Relapsed/Refractory Large B-Cell Lymphoma: The Role of KIR Matching.

Frederick L Locke, John B Le Gall, Paul W Fisher

|May 22, 2025

Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.

Benjamin Diamond, Dhanvantri Chahar, Michael D Jain

Pageof 7

Frequent Collaborators

15 joint publications

Michael Jain

10 joint publications

Olalekan Oluwole

David B Miklos

Taiga Nishihori

Sattva S Neelapu

Marco L Davila

Jason Westin

Aleksandr Lazaryan

Michael Wang

Joseph P Mcguirk

Frequent Collaborators

15 joint publications

Michael Jain

10 joint publications

Olalekan Oluwole

9 joint publications

David B Miklos

7 joint publications

Taiga Nishihori